Caitlin Raymond: The People With “Golden Blood”
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared a post on LinkedIn:
”There is no supply chain for golden blood. There is a short list of names.
In 1961, a blood bank in Melbourne ran a routine test on an Aboriginal Australian woman and found nothing. No reaction to anti-D, anti-C, anti-E, none of it. She had Rh-null, the phenotype missing the entire Rh antigen system rather than just the single antigen most of us mean when we say “Rh negative.”
Sixty-some years later, fewer than 50 people worldwide are confirmed to have it. Maybe nine are actively donating at any given time.
You can’t stockpile that the normal way:
Standard red cells last approximately 42 days refrigerated
Rh-null units get frozen and glycerolized instead, stretching shelf life to a decade or more
A global registry (International Rare Donor Panel, run out of Bristol since 1965) tracks both the frozen units and the donors themselves
Here’s the part that stuck with me longest.
If you carry this phenotype, you’re advised to bank your own blood in advance, because waiting on the network in a true emergency is a bad plan with worse alternatives.
You’re advised to think twice before traveling somewhere without fast access to frozen rare stock.
You are, in a real sense, on call for people you will never meet, and they are on call for you.
I wrote about how this network actually works, and the question I couldn’t fully answer by the end: what do we owe the people who are, quite literally, irreplaceable?”

Other posts featuring Caitlin Raymond on Hemostasis Today.
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India